Eli Lilly starts website to connect patients with new obesity treatment, Zepbound, other drugs

by

Eli Lilly has launched a unique website to connect U.S. patients seeking obesity treatment to doctors, dieticians and its new weight-loss drug, Zepbound.

Leave A Comment

Your email address will not be published. Required fields are marked *